Risk and Management of Blood-borne Infections in Health Care Workers

Overview

Journal Clin Microbiol Rev

Publisher American Society for Microbiology

Specialty Microbiology

Date 2000 Jul 25

PMID 10885983

Citations 126

Authors

E M Beltrami

I T Williams

C N Shapiro

M E Chamberland

Affiliations

Soon will be listed here.

Abstract

Exposure to blood-borne pathogens poses a serious risk to health care workers (HCWs). We review the risk and management of human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV) infections in HCWs and also discuss current methods for preventing exposures and recommendations for postexposure prophylaxis. In the health care setting, blood-borne pathogen transmission occurs predominantly by percutaneous or mucosal exposure of workers to the blood or body fluids of infected patients. Prospective studies of HCWs have estimated that the average risk for HIV transmission after a percutaneous exposure is approximately 0.3%, the risk of HBV transmission is 6 to 30%, and the risk of HCV transmission is approximately 1.8%. To minimize the risk of blood-borne pathogen transmission from HCWs to patients, all HCWs should adhere to standard precautions, including the appropriate use of hand washing, protective barriers, and care in the use and disposal of needles and other sharp instruments. Employers should have in place a system that includes written protocols for prompt reporting, evaluation, counseling, treatment, and follow-up of occupational exposures that may place a worker at risk of blood-borne pathogen infection. A sustained commitment to the occupational health of all HCWs will ensure maximum protection for HCWs and patients and the availability of optimal medical care for all who need it.

Citing Articles

Exposure to needlestick injury among healthcare support staff in Greater Accra, Ghana: a cross-sectional study.

Tawiah P, Appiah-Brempong E, Okyere P, Ashinyo M BMJ Public Health. 2025; 2(1):e000681.

PMID: 40018102 PMC: 11812837. DOI: 10.1136/bmjph-2023-000681.

Immunity Protection of Pregnant Employees Working in the Healthcare Sector.

Seidling M, Goertzen S, Schmid K, Drexler H, Wolfschmidt A Geburtshilfe Frauenheilkd. 2025; 85(2):200-209.

PMID: 39925950 PMC: 11802197. DOI: 10.1055/a-2462-5707.

Surveillance and prevention of infection in clinical xenotransplantation.

Stewart A, Fishman J Clin Microbiol Rev. 2025; 38(1):e0015023.

PMID: 39887237 PMC: 11905366. DOI: 10.1128/cmr.00150-23.

Prevalence of hepatitis B surface antibody among previously vaccinated healthcare workers in Tashkent, Uzbekistan.

Ibragimov R, Nabirova D, Denebaeva A, Kurbanov B, Horth R Hum Vaccin Immunother. 2024; 20(1):2435142.

PMID: 39693189 PMC: 11789720. DOI: 10.1080/21645515.2024.2435142.

A paradigm shift in the detection of bloodborne pathogens: conventional approaches to recent detection techniques.

Khanal S, Pillai M, Biswas D, Islam M, Verma R, Kuca K EXCLI J. 2024; 23:1245-1275.

PMID: 39574968 PMC: 11579516. DOI: 10.17179/excli2024-7392.

References

Gretch D, dela Rosa C, Carithers Jr R, Willson R, Williams B, Corey L . Assessment of hepatitis C viremia using molecular amplification technologies: correlations and clinical implications. Ann Intern Med. 1995; 123(5):321-9. DOI: 10.7326/0003-4819-123-5-199509010-00001. View

Noskin G . Prevention, diagnosis, and management of viral hepatitis. A guide for primary care physicians. AMA Advisory Group on Prevention, Diagnosis, and Management of Viral Hepatitis. Arch Fam Med. 1995; 4(11):923-34. DOI: 10.1001/archfami.4.11.923. View

Mitsui T, Iwano K, Masuko K, Yamazaki C, Okamoto H, Tsuda F . Hepatitis C virus infection in medical personnel after needlestick accident. Hepatology. 1992; 16(5):1109-14. View

Guptan R, Thakur V, Sarin S, Banerjee K, Khandekar P . Frequency and clinical profile of precore and surface hepatitis B mutants in Asian-Indian patients with chronic liver disease. Am J Gastroenterol. 1996; 91(7):1312-7. View

Connor E, Sperling R, Gelber R, Kiselev P, Scott G, OSullivan M . Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1994; 331(18):1173-80. DOI: 10.1056/NEJM199411033311801. View

. Recommendations for preventing transmission of human immunodeficiency virus and hepatitis B virus to patients during exposure-prone invasive procedures. MMWR Recomm Rep. 1991; 40(RR-8):1-9. View

. Update: provisional Public Health Service recommendations for chemoprophylaxis after occupational exposure to HIV. MMWR Morb Mortal Wkly Rep. 1996; 45(22):468-80. View

. Case-control study of HIV seroconversion in health-care workers after percutaneous exposure to HIV-infected blood--France, United Kingdom, and United States, January 1988-August 1994. MMWR Morb Mortal Wkly Rep. 1995; 44(50):929-33. View

Pawlotsky J . Measuring hepatitis C viremia in clinical samples: can we trust the assays?. Hepatology. 1997; 26(1):1-4. DOI: 10.1002/hep.510260131. View

10.

Ou C, Ciesielski C, Myers G, Bandea C, Luo C, Korber B . Molecular epidemiology of HIV transmission in a dental practice. Science. 1992; 256(5060):1165-71. DOI: 10.1126/science.256.5060.1165. View

11.

Denes A, Smith J, MAYNARD J, DOTO I, Berquist K, FINKEL A . Hepatitis B infection in physicians. Results of a nationwide seroepidemiologic survey. JAMA. 1978; 239(3):210-12. View

12.

Jagger J, Hunt E, Pearson R . Sharp object injuries in the hospital: causes and strategies for prevention. Am J Infect Control. 1990; 18(4):227-31. DOI: 10.1016/0196-6553(90)90163-m. View

13.

Carman W, van Deursen F, Mimms L, Hardie D, Coppola R, Decker R . The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia. Hepatology. 1997; 26(6):1658-66. DOI: 10.1002/hep.510260640. View

14.

Halle M . Patients want ban on operations by doctors with hepatitis B. BMJ. 1996; 313(7057):576. PMC: 2352062. DOI: 10.1136/bmj.313.7057.576a. View

15.

Tsude K, Fujiyama S, Sato S, Kawano S, Taura Y, Yoshida K . Two cases of accidental transmission of hepatitis C to medical staff. Hepatogastroenterology. 1992; 39(1):73-5. View

16.

Sanchez-Quijano A, Pineda J, Lissen E, Leal M, Garcia de Pesquera F, Rivera F . Prevention of post-transfusion non-A, non-B hepatitis by non-specific immunoglobulin in heart surgery patients. Lancet. 1988; 1(8597):1245-9. DOI: 10.1016/s0140-6736(88)92071-5. View

17.

Sattar S, Springthorpe V . Survival and disinfectant inactivation of the human immunodeficiency virus: a critical review. Rev Infect Dis. 1991; 13(3):430-47. DOI: 10.1093/clinids/13.3.430. View

18.

Hsu H, Wright T, Luba D, Martin M, Feinstone S, Garcia G . Failure to detect hepatitis C virus genome in human secretions with the polymerase chain reaction. Hepatology. 1991; 14(5):763-7. DOI: 10.1002/hep.1840140504. View

19.

Jagger J, Hunt E, Pearson R . Rates of needle-stick injury caused by various devices in a university hospital. N Engl J Med. 1988; 319(5):284-8. DOI: 10.1056/NEJM198808043190506. View

20.

Prince A . Challenges for development of hepatitis C virus vaccines. FEMS Microbiol Rev. 1994; 14(3):273-7. DOI: 10.1111/j.1574-6976.1994.tb00099.x. View